Featured Research

from universities, journals, and other organizations

MRSA declines in veteran's hospitals nationwide

Date:
October 29, 2013
Source:
Elsevier
Summary:
Five years after implementing a national initiative to reduce MRSA rates in Veterans Affairs (VA) medical centers, cases have continued to decline, according to a study.

Five years after implementing a national initiative to reduce methicillin-resistant Staphylococcus aureus (MRSA) rates in Veterans Affairs (VA) medical centers, MRSA cases have continued to decline, according to a study in the November issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).

The MRSA Prevention Initiative, implemented in 2007, resulted in significant decreases in both the transmission (colonization with the organism) of MRSA (17 percent for intensive care units [ICUs] and 21 percent for non-ICUs) and healthcare-associated infection (HAI) rates within the hospitals (62 percent for ICUs, 45 percent for non-ICUs). In the two-year period following the first wave of the initiative (data previously published[i]), both MRSA transmissions and HAIs continued to decrease in non-ICU settings (declining an additional 13.7 percent and 44.8 percent, respectively), while holding steady in ICUs.

The MRSA Prevention Initiative utilizes a bundled approach that includes screening every patient for MRSA, use of gowns and gloves when caring for patients colonized or infected with MRSA, hand hygiene, and an institutional culture change focusing on individual responsibility for infection control. It also created the new position of MRSA Prevention Coordinator at each medical center.

"The analysis…shows that over the ensuing 24 months, MRSA transmission and MRSA HAI rates continued to decrease nationwide," state the authors. "Detailed analysis showed that there were statistically significant declines in MRSA transmissions and MRSA HAIs in non-ICUs but not in the ICUs. The absence of statistically significant trends in the ICUs may be because MRSA transmission and MRSA HAI rates were low."

Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterium that is resistant to many antibiotics and an important cause of illness and sometimes death. In medical facilities, MRSA causes life-threatening bloodstream infections, pneumonia and surgical site infections. In the community, most MRSA infections are skin infections.


Story Source:

The above story is based on materials provided by Elsevier. Note: Materials may be edited for content and length.


Journal Reference:

  1. Martin E. Evans, Stephen M. Kralovic, Loretta A. Simbartl, Ron W. Freyberg, D. Scott Obrosky, Gary A. Roselle and Rajiv Jain. Veterans Affairs methicillin-resistant Staphylococcus aureus prevention initiative associated with a sustained reduction in transmissions and health care-associated infections. American Journal of Infection Control, October 2013

Cite This Page:

Elsevier. "MRSA declines in veteran's hospitals nationwide." ScienceDaily. ScienceDaily, 29 October 2013. <www.sciencedaily.com/releases/2013/10/131029104411.htm>.
Elsevier. (2013, October 29). MRSA declines in veteran's hospitals nationwide. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/10/131029104411.htm
Elsevier. "MRSA declines in veteran's hospitals nationwide." ScienceDaily. www.sciencedaily.com/releases/2013/10/131029104411.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins